40代ã®èã®ããªã«ãæ©ã¿ã®æ¹ãž
ã20代ã®é ãšã¯æããã«éãããšããæèŠã¯30代ã«ããã£ããã®ã®ã40代ã«å ¥ã£ãŠãããã®å€åã®ã¹ããŒããå€ãã£ããšæããæ¹ãå€ãããã£ããããŸããæèµ·ãããšãã«é¡ã以åããéãæãããæŒããŠããå ã«æ»ãèã®åŸ©å åãç®ã«èŠããŠé ããªã£ãããšãã£ãã声ãã«ãŠã³ã»ãªã³ã°ã«ãŒã ã§ãã䌺ããŸãã
ãã®èšäºã§ã¯ããã®çç±ãäœãªã®ãããããŠ40代ãšãã幎代ã«åã£ãããªç®¡çã®æ¹åæ§ãã©ãèããã°ãããã«çŠç¹ãåœãŠãŠæŽçããŸãããèã®ããªäœäžã®ä»çµã¿å šè¬ãæ°ã«ãªãæ¹ã¯èã®ããªäœäžã®åå ã¬ã€ãããæœè¡ãªãã·ã§ã³ã®æŠèŠã¯èã®ããªæœè¡ã¬ã€ãã䜵ããŠãåç §ãã ããããã®èšäºã¯ãã®2ã€ã®èšäºãšéè€ããªãããã40ä»£ç¹æã®ãã«ã¢ã³å€åãšå¹Žä»£å¥ã®åªå é äœã«çŠç¹ãåœãŠãŠããŸãã
3è¡ãŸãšã
1. 40代ã®èã®ããªäœäžã¯åçŽãªèåã§ã¯ãªãããšã¹ããã²ã³æžå°ã«ããã³ã©ãŒã²ã³åæã®å éçãªäœäžãéèŠãªå€æ°ãšããŠå ãã幎代ã§ããéçµååŸã®5幎éã§èã³ã©ãŒã²ã³ãçŽ30%æžå°ãããšããç ç©¶å ±åïŒBrincat et al. 1987, Obstet GynecolïŒããããŸãã
2. 40代ã®ããªç®¡çã®åªå é äœã¯ãâ 玫å€ç·ã»ç掻管çã®åºç€ç¶æ â â¡ ã³ã©ãŒã²ã³åºæ¿æœè¡ã®æ€èš â ⢠ãªããã£ã³ã°ã»ããªã¥ãŒã è£å®ã®æ€èšã®é ã§ãæœè¡åã®å人ã®ç¶æ è©äŸ¡ãå¿ é ã§ãã
3. åã40代ã§ãèã®ç¶æ ã»ãã«ã¢ã³å€åã®çšåºŠã»çæŽ»ç¿æ £ãç°ãªããããåäžã®çµæãä¿èšŒããããšã¯ã§ãããå ·äœçãªæ¹åæ§ã¯äºåã«ãŠã³ã»ãªã³ã°ã§æ±ºå®ããŸãã
1. 40代ã®èã®ããªäœäžã¯ããªãç¹å¥ãªã®ã§ããããïŒ
èã®ããªäœäžã¯20代åã°ããå§ãŸããŸããã40代ã«ã¯ä»ã®å¹Žä»£ãšåºå¥ãããå€åãéãªããŸããèªç¶ãªèåã®ã¹ããŒãã«å ããŠããšã¹ããã²ã³æžå°ãšãããã«ã¢ã³ã®å€æ°ãæ¬æ Œçã«é¢ãã£ãŠããããã§ãã
ãšã¹ããã²ã³ãšã³ã©ãŒã²ã³ã®ã€ãªãã
ãšã¹ããã²ã³ã¯èã®ç·ç¶èœçްèïŒfibroblastïŒãåºæ¿ããŠã³ã©ãŒã²ã³åæãå©ãã圹å²ãæ ã£ãŠããŸãã40代ååããåŸã ã«æžå°ãå§ãããšã¹ããã²ã³ã¯ãéçµãååŸããŠæ¥æ¿ã«äœäžããŸããããã®ææã«èã®ã³ã©ãŒã²ã³éã䜵ããŠæžå°ããããšããè€æ°ã®ç ç©¶ã§å ±åãããŠããŸãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå ž: Brincat et al., Obstet Gynecol 1987 (PMID 3120067) · Castelo-Branco et al., Maturitas 1992 (PMID 1345134) · Affinito et al., Maturitas 1999 (PMID 10656502)
- éçµåŸã®èã³ã©ãŒã²ã³éã¯å¹Žéã§çŽ1ã2%æžå°ãããšããå ±åããããŸããïŒBrincat et al. 1987, PMID 3120067, Obstet GynecolïŒ
- Castelo-Branco et al. 1992ïŒPMID 1345134, Maturitas, ç®èçæ€312ä»¶ïŒã§ã¯ãã40代以éã§ã³ã©ãŒã²ã³éãææã«æžå°ïŒp<0.001ïŒãããéçµåŸã«ããé¡èã«ãªããšå ±åããŠããŸãã
- Affinito et al. 1999ïŒPMID 10656502, MaturitasïŒã§ã¯ãéçµåŸã®å¥³æ§ã§Type Iã»III ã³ã©ãŒã²ã³ãããããææã«æžå°ïŒp<0.01ïŒããéçµæéãé·ãã»ã©ã³ã©ãŒã²ã³å€ãäœããªãè² ã®çžé¢ïŒr=0.76ã»0.73ïŒã確èªããŸããã
- ãéçµååŸã®5幎éã§ã³ã©ãŒã²ã³30%æžå°ãã¯è€æ°ã®æç®ã§åŒçšãããæšå®å€ã§ãããæ°å€ã®æ£ç¢ºãªæ ¹æ ã¯ç ç©¶ããšã«æ¹æ³è«ãç°ãªããå人差ã倧ãããã®ã§ãã
- 广ã»å€åã®çšåºŠã¯å人ã®èã®ç¶æ ã»ãã«ã¢ã³ã¬ãã«ã«ãã£ãŠå·®ããããŸãã
ãšã©ã¹ãã³ã®å€åã䜵ããŠé²ã¿ãŸã
ã³ã©ãŒã²ã³ã ãã§ãªããèã®åŒŸæ§ãæ ããšã©ã¹ãã³ïŒElastinïŒã40代以éã«æ§é çãªå€åãçµãŸããæäººã®èã«ãããŠãšã©ã¹ãã³ã¯ãäžåºŠæå·ãããšã»ãšãã©ååæãããªãã¿ã³ãã¯è³ªãšããŠç¥ãããŠãããé·å¹Žèç©ãã玫å€ç·æé²ïŒå èåïŒãé žåã¹ãã¬ã¹ããã®ææã«å¢å¹ ãããŠçŸããŸããããã¯èãæŒãããšãã«ãå ã«æ»ãã¹ããŒãïŒåŸ©å åïŒããç®ã«èŠããŠé ããªãåå ã®ã²ãšã€ã§ãã
ç®äžèèªå±€ã®å€å
40代ã«ã¯ç®äžèèªã®ååžãå€ããããšã§ãé ¬ã»ãããã¿ãªã©é¡ã®ç¹å®ã®éšäœã§ããªã¥ãŒã ã®æžå°ãã¯ã£ããçŸããå ŽåããããŸããããã¯ããªäœäžãšã¯ç¬ç«ããå€åã§ããããã®2ã€ãåæã«é²ããšããã¿ãšèããå°è±¡ãããç®ç«ã£ãŠèŠããŸããããªäœäžãšããªã¥ãŒã æžå°ãåºå¥ããŠèŠãããšããé©åãªç®¡çã®æ¹åæ§ãèŠã€ããç¬¬äžæ©ã§ãã
2. 40代ã®ããªäœäžã®ç¹åŸŽ â ã²ãšç®ã§èŠã
| å€åèŠçŽ | 20ã30代åå | 40代ïŒç¹åŸŽçãªå€åïŒ |
|---|---|---|
| ã³ã©ãŒã²ã³æžå°ã®ã¹ããŒã | ç·©ããã§æŒžé²çãªæžå° | ãšã¹ããã²ã³æžå°ãšçžãŸã£ãŠå éããåŸåïŒåäººå·®å€§ïŒ |
| ãšã¹ããã²ã³ã®ã¬ãã« | æ¯èŒçå®å® | 40代ååããæžå°éå§ãéçµååŸã«æ¥æžã®å¯èœæ§ |
| ãšã©ã¹ãã³ã®åŸ©å å | æ¯èŒçéãããªåŸ©å | å èåã®èç©ïŒåŸ©å ã¹ããŒãã®äœäžã宿 |
| ç®äžèèª | æ¯èŒçåäžãªååž | ç¹å®éšäœïŒé ¬ã»ãããã¿ïŒã®ããªã¥ãŒã æžå°ã宿ããå¯èœæ§ |
| äž»ã«å®æããå€å | å°ããã»èã®ãã | ããã¿ã»ããªã¥ãŒã æžå°ã»é¡ã®èŒªéå€åã®è€å |
â» äžèšã®è¡šã¯äžè¬çãªåŸåãæŽçãããã®ã§ãããå人ã®éºäŒã»çæŽ»ç¿æ £ã»ãã«ã¢ã³ã¬ãã«ã«ãã£ãŠå·®ã倧ããåºãŸãã幎霢ã ãã§ç®¡çã®æ¹åæ§ã決ãŸãããã§ã¯ãªãããèªèº«ã«ã©ã®å€åãæãé¡èãªã®ãã¯ã«ãŠã³ã»ãªã³ã°ãéããŠè©äŸ¡ããŸãã
3. çæŽ»ç®¡ç â 40代ã®ããªç¶æã®åºç€
æœè¡ã®åã«å¿ ãæŒãããŠããã¹ãéšåã¯ç掻管çã®åºç€ã§ããã©ãã»ã©è¯ãæœè¡ãããŠãã玫å€ç·å¯Ÿçãç¡ç ã»æ é€ç®¡çã厩ããŠãããšçµæãé·ãç¶æããã«ãããªããŸãã40代ã®ããªç®¡çã«ãããŠç掻管çã¯ãéžæãªãã·ã§ã³ãã§ã¯ãªããæœè¡å¹æãæ¯ããåå°ã§ãã
玫å€ç·å¯Ÿç â æãæ ¹æ ã®ããåºç€
å èåïŒphotoagingïŒã¯ãšã©ã¹ãã³æ§é ãå€åœ¢ãããMMPïŒãããªãã¯ã¹ã¡ã¿ããããã¢ãŒãŒïŒã®æŽ»æ§ãé«ããŠã³ã©ãŒã²ã³åè§£ãä¿é²ããŸããSPF 30以äžã®æ¥çŒãæ¢ããæ¯æ¥äœ¿ãããšããããªç¶æã«ãããŠæãæ ¹æ ã®ããç¿æ £ã®ã²ãšã€ã§ãã倩åã«é¢ä¿ãªãã宀å ã§ãçªèŸºã®è¿ãã§ããã°çŽ«å€ç·ã«æé²ãããŸãã
ç¡ç â ã³ã©ãŒã²ã³åæã掻çºã«ãªãæé
ç¡ç äžã«ã¯æé·ãã«ã¢ã³ã®åæ³ãå¢ããè现èã®åçãšã³ã©ãŒã²ã³åæãçžå¯Ÿçã«æŽ»çºã«ãªãããšãç¥ãããŠããŸãã7æé以äžã®ç¡ç ã確ä¿ããããšã¯ãèã®åçãµã€ã¯ã«ãå®ãããã§éèŠã§ããç¡ç äžè¶³ã¯ã³ã«ããŸãŒã«å€ãé«ããã³ã©ãŒã²ã³åè§£ã鿥çã«åºæ¿ããå ŽåããããŸãã
æ é€ â ã³ã©ãŒã²ã³åæãæ¯ããæå
ã³ã©ãŒã²ã³åæã«ã¯ãã¿ãã³Cãè£å©å åïŒcofactorïŒãšããŠå¿ èŠã§ããæ°é®®ãªéèãæç©ãéããŠç¶ç¶çã«æåããã®ãè¯ãã§ããããã¿ã³ãã¯è³ªã®æåããã¢ããé žã®äŸçµŠãšããé¢ã§æ¬ ãããŸããããã ããç¹å®ã®é£åããµããªã¡ã³ããèã®ããªãçŽæ¥ãå埩ãããããšãã£ãæå®çãªäž»åŒµã¯æ§ããã¹ãã§ããã©ã³ã¹ã®åããé£äºãåºæ¬ã§ãã
çŠç ã»ç¯é
å«ç ã¯èã®è¡æµãæžå°ãããé žåã¹ãã¬ã¹ãé«ããŠã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ã®åè§£ãå éããŸããã¢ã«ã³ãŒã«ã®éå°æåãäœå ã®æ°Žåãã©ã³ã¹ã厩ããæ é€åžåã劚ããŠèã®å埩åã«è² æ ããããŸãããã®2ã€ã¯ãã©ã®æœè¡ãããå ã«èª¿æŽãã¹ãçæŽ»äžã®å€æ°ã§ãã
4. 40代ã®ããªå埩 â æœè¡ãªãã·ã§ã³ã®æŠèг
çæŽ»ç®¡çãåºç€ã«çœ®ããå人ã®ç¶æ ã«å¿ããŠæœè¡ã䜵ããŠæ€èšããæµãããã»ãªããã¯å»é¢(Cellinique)ã®åºæ¬çãªã«ãŠã³ã»ãªã³ã°æ¹éã§ããããã§ã¯40代ã®ããªå埩ã«é¢é£ããŠããæ€èšãããæœè¡ã®çš®é¡ãäžè¬çãªãæ¡å ã®ã¬ãã«ã§æŽçããŸããã©ã®æœè¡ããèªèº«ã«é©ããŠãããã¯ãäºåã«ãŠã³ã»ãªã³ã°ãšèã®è©äŸ¡ã®ããã§æ±ºå®ããŸãã
â ã³ã©ãŒã²ã³åºæ¿æœè¡ â ã¹ãã³ããŒã¹ã¿ãŒç³»
ãžã¥ãã«ãã¯(Juvelook)ïŒPDLLA + HAïŒããªãžã¥ã©ã³(Rejuran)ïŒPNç³»ïŒãªã©ã¯ãçç®ã«æåãæ³šå ¥ããŠç·ç¶èœçްèãåºæ¿ããã³ã©ãŒã²ã³åæãå©ããæ¹åã«äœçšããã¹ãã³ããŒã¹ã¿ãŒã§ãã40代ã®èã§ã³ã©ãŒã²ã³åæã®ã¹ããŒããé ããªã£ãç¶æ ãè£ãæ¹åã§æ€èšã§ããŸãããã ãæœè¡æ¹æ³ã»æåã»é©å¿ã¯è£œåããšã«ç°ãªããå¹æã»æç¶æéã«ã¯å人差ã倧ããã§ããã¹ãã³ããŒã¹ã¿ãŒéã®éããæ°ã«ãªãæ¹ã¯ããªãžã¥ã©ã³ vs ãžã¥ãã«ã㯠æ¯èŒã¬ã€ãããåç §ãã ããã
â¡ ãšãã«ã®ãŒããŒã¹ã®ãªããã£ã³ã°æœè¡ â HIFUç³»
é«å¯åºŠçŠç¹åŒè¶ 鳿³¢ïŒHIFU, High-Intensity Focused UltrasoundïŒã¯ãèã®æ·±éšã®SMASå±€ïŒè¡šåšæ§çèç³»ïŒãŸã§ ãšãã«ã®ãŒãäŒããŠçµç¹ãåºæ¿ããã³ã©ãŒã²ã³ã®å圢æãä¿ãæ¹åŒã§ãã40代ã§å®æããããã¿ã»èŒªéã®å€åã«å¯ŸããŠæ€èšã§ããéžæè¢ã®ã²ãšã€ã§ãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå ž: Haykal et al., Aesthetic Surgery Journal 2025 (PMID 40184185) â HIFU ã®èã®ããªã»èŒªéæ¹åã«é¢ãã系統çã¬ãã¥ãŒ
- Haykal et al. 2025 ã®ç³»çµ±çã¬ãã¥ãŒïŒPMID 40184185ïŒã§ã¯ãHIFU ãèã®ããã¿æ¹åã«ãããŠ18ã30%ã®ç¯å²ã®æ¹åãå ±åããç ç©¶ãå«ãã§ããŸããã
- æå®³äºè±¡ã¯5%æªæºã§ãäžæçãªçŽ æã»æµ®è «ã»è»œåºŠã®äžå¿«æãå ±åãããŸããã
- ãã ããããã¯èšåºç ç©¶ã®éèšããŒã¿ã§ãããå人ã®èã®ç¶æ ã»æœè¡ãããã³ã«ã«ãã£ãŠå¹æãšåå¿ã¯ç°ãªã£ãŠçŸããŸããåäžã®çµæãä¿èšŒãããã®ã§ã¯ãããŸããã
⢠ããªã¥ãŒã è£å® â ãã£ã©ãŒã»ãã€ãªã¹ãã£ãã¥ã¬ãŒã¿ãŒç³»
40代ã§èгå¯ãããé ¬ã»ãããã¿ã®ããªã¥ãŒã æžå°ã«å¯ŸããŠã¯ãHAãã£ã©ãŒããã€ãªã¹ãã£ãã¥ã¬ãŒã¿ãŒïŒèªå®¶ã³ã©ãŒã²ã³ãèªå°ãã補å€ïŒç³»ã䜵ããŠæ€èšããå ŽåããããŸããããªæ¹åãšããªã¥ãŒã è£å®ã¯äºãã«ç°ãªãåé¡ãæ±ãããã2ã€ãäžåºŠã«è§£æ±ºããããšããããããã«ãŠã³ã»ãªã³ã°ã§åªå é äœãå ã«æ±ºããããšãéèŠã§ãã
⣠èªå·±èèªç±æ¥çްèïŒSVFïŒæœè¡ â åå¥ã®ã«ãŠã³ã»ãªã³ã°ãå¿ èŠ
èªå·±ã®èèªããæ¡åããçŽ°èæ··åç©ã§ããSVFïŒé質è¡ç®¡çްè矀, stromal vascular fractionïŒãçšããæœè¡ããäžéšã§æ€èšãããŠããŸããSVFã¯çŽç²ãªå¹¹çްèã§ã¯ãªããèèªçµç¹ããåé¢ãã现èã®æ··å矀ïŒé質现èã»è¡ç®¡å ç®çްèã»å ç«çްèãªã©ãå«ãïŒã§ããããå¹¹çŽ°èæ³šå°ããŸãã¯ãå¹¹çŽ°èæ²»çããšã¯åºå¥ãããæŠå¿µã§ãããã®æœè¡ã®é©çšã®å¯åŠã»æ¹åŒã¯å人ã®ç¶æ ã«ãã£ãŠç°ãªãããããé¢å¿ã®ããæ¹ã¯ã«ãŠã³ã»ãªã³ã°ã§è©³ãããæ¡å ãåããããããšããå§ãããŸãã
â ïž è¡šèšã«é¢ããæ³šæ â SVFæœè¡ã¯å»çæ³ããã³åŠè¡çåæïŒIFATS/ISCT åæå®çŸ©, PMID 23570660ïŒã«åŸãããèªå·±èèªç±æ¥çްèïŒSVFïŒæœè¡ããšè¡šèšããŸãããå¹¹çŽ°èæ³šå°ããŸãã¯ãå¹¹çŽ°èæ²»çããšæå®ãã衚çŸã¯äœ¿çšããŸããã
5. 40代ã®ããªç®¡ç â 幎代å¥ã®åªå é äœãèããŠã¿ã
æœè¡ãªãã·ã§ã³ãããã€ããã£ãŠãããã©ãããå§ããã°ããã®ããã¯éæ¹ã«æ®ããæèŠã«ãªããã¡ã§ããã»ãªããã¯å»é¢(Cellinique)ã§ã¯ã40代ã®ããªã®ã«ãŠã³ã»ãªã³ã°ã§éåžžã以äžã®ãããªé åºã§èããŠãããŸããããã¯å人差ãèæ ®ããäžè¬çãªãã¬ãŒã ã§ããããèªèº«ã®åªå é äœã¯ã«ãŠã³ã»ãªã³ã°ã§ç°ãªãå ŽåããããŸãã
| åªå é äœ | æ¹å | çç± |
|---|---|---|
| 第1åªå | 玫å€ç·å¯Ÿçã»ç掻管çã®åºç€ã®ç¢ºä¿ | æœè¡å¹æãæç¶ãããåå°ãå èåã®æå¶ |
| 第2åªå | ã³ã©ãŒã²ã³åºæ¿ã®æ¹åã®æœè¡ã®æ€èšïŒã¹ãã³ããŒã¹ã¿ãŒç³»ïŒ | ãšã¹ããã²ã³æžå°ã§é ããªã£ãã³ã©ãŒã²ã³åæãè£ãæ¹å |
| 第3åªå | ããã¿ã»ãªããã£ã³ã°ã®æ¹åã®æ€èšïŒHIFU ãªã©ïŒ | é ¬ã®ããã¿ã»èŒªéå€åãé¡èãªå Žåã«è¿œå æ€èš |
| è¿œå æ€èš | ããªã¥ãŒã è£å®ïŒãã£ã©ãŒã»ãã€ãªã¹ãã£ãã¥ã¬ãŒã¿ãŒïŒ | ããªæ¹åãšããªã¥ãŒã è£å®ãåºå¥ããããã§ãå¿ èŠã«å¿ããŠäœµè¡ |
â» äžèšã®é åºã¯ãäžè¬çãªã«ãŠã³ã»ãªã³ã°ã®æµãã®åèãã¬ãŒã ã§ããå®éã®é©çšã®å¯åŠãé åºã¯ãå人ã®èã®ç¶æ ã»éå»ã®æœè¡æŽã»ãã«ã¢ã³ã®ç¶æ ã»çæŽ»ç¿æ £ã«ãã£ãŠç°ãªããŸããè€æ°ã®æœè¡ãåæã«ããŸãšããŠãé²ããã®ã§ã¯ãªããã«ãŠã³ã»ãªã³ã°ã§é åºãšééãäžç·ã«èšèšããŸãã
6. ã»ãªããã¯å»é¢(Cellinique)ã§40代ã®ããªã®ã«ãŠã³ã»ãªã³ã°ãåãããªã
ã»ãªããã¯å»é¢(Cellinique)ã¯ããœãŠã«æ±ååºããµã³ããã«äœçœ®ããå»é¢ã§ãã40代ã®ããªã®ã«ãŠã³ã»ãªã³ã°ã§ã¯ããã ã»ãŽã代衚é¢é·ãèã®ç¶æ è©äŸ¡ãšãšãã«ç掻管çã®åºç€ããŸãæŒãããã©ã®æ¹åã®æœè¡ãå®è³ªçã«åœ¹ç«ã€ããäžç·ã«æŽçããæ¹åŒã§é²ããŸãã
ã²ãšã€ã®æœè¡ã決ããŠãããè¶ãã«ãªãããããã40代ã«å ¥ã£ãŠãããã®ãããªå€åãçããããšãããæ©ã¿ãæ°è»œã«ã話ãããã ããã°ããã®æèã®äžã§æ¹åæ§ãäžç·ã«æ¢ããŠãŸãããŸããããªã»ãªããã£ã³ã°ã»ããªã¥ãŒã ã®ãã¡ãã©ãã«æãäžå¿«æãæããŠããã£ããããã«ãã£ãŠãã¢ãããŒããç°ãªãå ŽåããããŸãã
çµæã»æç¶æéã»é©åã®å¯åŠã¯ãå人ã®èã®ç¶æ ã»å¹Žéœ¢ã»ç掻ãã¿ãŒã³ã«ãã£ãŠå·®ããããåäžã®çµæãä¿èšŒããããšã¯ã§ããŸãããæœè¡ã«ã¯äžæçãªçŽ æã»æµ®è «ãªã©ã®å¯äœçšã®å¯èœæ§ããããçŠå¿äºé ãããå Žåããããããäºåã«ãŠã³ã»ãªã³ã°ã§ç¢ºèªããŸãã
ãããã質åïŒFAQïŒ
Q1. 40代ã®èã®ããªäœäžã30代ããéãæããããçç±ã¯ãããŸããïŒ
ãããŸãã30代ã§ãèªç¶ãªèåã«ããã³ã©ãŒã²ã³æžå°ã¯é²ã¿ãŸããã40代ã¯ãšã¹ããã²ã³ãæžå°ãå§ããææãšéãªãå Žåãå€ãã§ãããšã¹ããã²ã³ã¯èã®ç·ç¶èœçްèãåºæ¿ããŠã³ã©ãŒã²ã³åæãå©ãã圹å²ãæ ã£ãŠããŸããããããæžããšã³ã©ãŒã²ã³æžå°ã®ã¹ããŒããå éããæ¹åã«äœçšããå ŽåããããŸããå人ã®ãã«ã¢ã³ã®ç¶æ ã»çæŽ»ç¿æ £ã»éºäŒã«ãã£ãŠã宿ã®å·®ã¯å€§ããç°ãªããŸãã
Q2. 40代ã§ããªæœè¡ãå§ããã®ã¯é ãããã®ã§ã¯ãªãã§ããããïŒ
é ãã¯ãããŸãããããªç®¡çã®å¹æã¯ãå§ããææããããèªèº«ã®ç¶æ ã«åã£ãæ¹åæ§ãå®ããããšã®ã»ããéèŠã§ããèã®ç¶æ ãé²ãã»ã©æœè¡æéãé·ããªãå Žåããããšããç¹ã§ããããå€åã宿ããæç¹ã§ã«ãŠã³ã»ãªã³ã°ãåããŠã¿ãã®ãè¯ãã§ãããããã ããã©ã®ãããªæœè¡ã§ãããäžåºŠã§å®å šã«å ã«æ»ãã广ãä¿èšŒãããã®ã§ã¯ãããŸããã
Q3. ãã«ã¢ã³å€åãèã«äžãã圱é¿ãããã»ã©å€§ãããªãããã«ã¢ã³æ²»çãæ€èšãã¹ãã§ããããïŒ
ãã«ã¢ã³çæ³ïŒHRTïŒã¯èã ãã§ãªãå šèº«ã®å¥åº·ã«åœ±é¿ãäžããæ²»çã§ãã®ã§ãèã®ããªã ããç®çã«æ±ºããããããç£å©Šäººç§ã»å ç§ã®å°éå»ãšã®ååãªã«ãŠã³ã»ãªã³ã°ãéããŠæ±ºå®ãããã®ãé©åã§ããã»ãªããã¯å»é¢(Cellinique)ã§ã¯èã®æœè¡ã®é¢ã§ã®ç®¡çããæ¡å ããŠããããã«ã¢ã³æ²»çèªäœã«é¢ããåŠæ¹ã»æ±ºå®ã¯ããã®å°éé åã§è¡ãããã¹ããã®ã§ãã
Q4. HIFUãšã¹ãã³ããŒã¹ã¿ãŒã®ãã¡ãã©ã¡ããå ã«åããã®ãè¯ãã§ããïŒ
ãã®2ã€ã®æœè¡ã¯ãäœçšããå±€ãšç®çãç°ãªããŸããã¹ãã³ããŒã¹ã¿ãŒã¯çç®ã«æåãçŽæ¥äŸçµŠããŠã³ã©ãŒã²ã³åºæ¿ãå©ããHIFUã¯ãšãã«ã®ãŒã§æ·±ãå±€ïŒSMASïŒãŸã§åºæ¿ããŠãªããã£ã³ã°ã»èŒªéã®æ¹åãè£å®ããŸããã©ã¡ããå ãã¯ã仿ãé¡èãªãæ©ã¿ïŒèã®ããã»ã㪠vs. ããã¿ã»èŒªéïŒã«ãã£ãŠç°ãªããŸããã«ãŠã³ã»ãªã³ã°ã§äžç·ã«æ±ºããã®ãæãæ£ç¢ºã§ãã
Q5. ã¹ãã³ã±ã¢è£œåã ãã§ã40代ã®ããªå埩ã¯å¯èœã§ããïŒ
ã¹ãã³ã±ã¢è£œåã¯è衚é¢ã®æ°Žåã»ããªã¢ç®¡çã«ã¯åœ¹ç«ã¡ãŸãããçç®å ã®ã³ã©ãŒã²ã³æžå°ãçŽæ¥å ã«æ»ãã«ã¯éçããããŸããã¬ãããŒã«ïŒãã¿ãã³Aèªå°äœïŒé å補åã¯ã³ã©ãŒã²ã³åæã鿥çã«å©ãããšããç ç©¶çµæããããŸãããæ¿åºŠã»äœ¿çšæéã«ãã£ãŠå¹æãšåºæ¿ã®å¯èœæ§ãç°ãªããŸããåºç€ã¹ãã³ã±ã¢ã¯ç掻管çã®åºç€ã§ãããçç®ã¬ãã«ã®å€åãããç©æ¥µçã«æ±ãããå Žåã¯ãæœè¡ãªãã·ã§ã³ã䜵ããŠæ€èšããŠã¿ãã®ãçŸå®çã§ãã
Q6. 40代ã«é©ããæœè¡ã®åæ°ã»åšæã¯ã©ã®ãããã§ããïŒ
æœè¡ã®çš®é¡ããšã«ç°ãªããåãæœè¡ã§ãã£ãŠãå人ã®èã®åå¿ãšç®æšã«ãã£ãŠç°ãªããŸããã40代ã ãããã®åšæã§è¡ãã¹ãããšããäžåŸã®åºæºã¯ãããŸãããäºåã«ãŠã³ã»ãªã³ã°ã§èã®ç¶æ ãè©äŸ¡ããããã§ãå人ã«åã£ãåæ°ãšééããæ¡å ããŸãã
Q7. ããªç®¡çãšäœµããŠãçŸçœã»æ¯ç©Žã±ã¢ãäžç·ã«åããããŸããïŒ
å¯èœãªå ŽåããããŸãããã ããè€æ°ã®ç®çã®æœè¡ãåæã«é²ãããšèãžã®åºæ¿ãéãªãå Žåããããããé åºãšééãåãããŠèšèšããããšãéèŠã§ããã©ã®ãæ©ã¿ãããåªå ããã«ãŠã³ã»ãªã³ã°ã§äžç·ã«æŽçããããã§ãé²è¡ã®é åºã決å®ããŸãã
Q8. ã«ãŠã³ã»ãªã³ã°ã ãåããããšã¯ã§ããŸããïŒ
ãã¡ããã§ããã©ã®æœè¡ãè¡ããæ±ºããŠããªãç¶æ ã§ããã«ãŠã³ã»ãªã³ã°ã ããåãããã ããŸãããä»ã®ç§ã®èã®ç¶æ ã§ããŸãäœããã¹ãããããäžç·ã«æŽçããŠãŸãããŸãã02-6203-3434 ãŸã㯠KakaoTalk ã§æ°è»œã«ãåãåãããã ãããã«ãŠã³ã»ãªã³ã°ã»æœè¡ã®è²»çšã¯å人ã®ç¶æ ã»èšèšã«ãã£ãŠç°ãªããããã«ãŠã³ã»ãªã³ã°ã§ãæ¡å ããŸãã
ãŸãšã
40代ã®èã®ããªäœäžã¯ãèªç¶ãªèåã«ãã«ã¢ã³å€åãå ããææã®è€åçãªå€åã§ããããæœè¡ããæµè¡ããŠãããã广ãããããšãã話ãèããŠéžã¶ããããä»ã®ç§ã®èã§å®éã«äœãå€ãã£ãŠããã®ãããŸãææ¡ããããšãéèŠã§ãã
玫å€ç·å¯Ÿçãšç掻管çãåºç€ã«çœ®ããå¿ èŠãªéšåã«æœè¡ãªãã·ã§ã³ãå ããæ¹åããé·æçã«å¹ççãªç®¡çã§ããããªäœäžã®åå ãšä»çµã¿ãããã«æ°ã«ãªãæ¹ã¯èã®ããªäœäžã®åå ã¬ã€ãããå ·äœçãªæœè¡ã®éžæè¢ã®æŠèŠã¯èã®ããªæœè¡ã¬ã€ãã䜵ããŠãåç §ãã ããã
ã»ãªããã¯å»é¢(Cellinique)ïŒæ±åããµã³ããïŒã§ã¯ããã ã»ãŽã代衚é¢é·ã40代ã®èã®å€åã®ç¹æ§ãšç掻管çã®åºç€ã䜵ããŠèŠãªãããæ¹åæ§ããæ¡å ããŸãããæ©ã¿ãããã°ããŸãã¯æ°è»œã«ãé£çµ¡ãã ããã
â ãã¡ã¯ããã§ãã¯å®äºã¬ããŒã
ãã®èšäºã®äž»ãªå»çã»ç§åŠæ å ±ã¯ã以äžã®åºå žããå®éã«fetchããã³ç¢ºèªããŸããã
- Brincat et al., Obstet Gynecol 1987 (PMID 3120067) â éçµåŸã®èã³ã©ãŒã²ã³ã»èã®åãã幎é1ã2%æžå°ãããšå ±å
- Castelo-Branco et al., Maturitas 1992 (PMID 1345134) â ç®èçæ€312ä»¶ã40代以éã®ã³ã©ãŒã²ã³æææžå°ïŒp<0.001ïŒã確èª
- Affinito et al., Maturitas 1999 (PMID 10656502) â éçµåŸã®Type Iã»III ã³ã©ãŒã²ã³æææžå°ãéçµæéãšã®è² ã®çžé¢ïŒr=0.76ã»0.73ïŒ
- Haykal et al., Aesthetic Surgery Journal 2025 (PMID 40184185) â HIFU ã®èã®ããã¿æ¹åã«é¢ãã系統çã¬ãã¥ãŒã18ã30%ã®æ¹åç¯å²ãå ±å
- IFATS/ISCT åæå®çŸ©, PMID 23570660 â SVFïŒé質è¡ç®¡çްè矀ïŒã®å®çŸ©: éå¹é€ã»çŽ°èæ··å矀ãçŽç²ãªå¹¹çްèã§ã¯ãªã
- æ€èšŒé ç®: ãšã¹ããã²ã³ã»ã³ã©ãŒã²ã³ã®é¢ä¿ïŒæ©åºïŒãã³ã©ãŒã²ã³æžå°ã®æ°å€ãHIFU ã®èšåºæ¹åçãSVF ã®è¡šèšååãçŠæ¢è¡šçŸã®éµå®ã®å¯åŠ
- 確èªäžå¯/éå®çãªåãæ±ã: ãéçµååŸã®5幎éã§30%æžå°ãã¯æšå®å€ãšããŠéæå®çãªè¡šçŸã䜿çšãåå¥ã®æ°å€ã»ç¹å®è£œåã®å¹æãä¿èšŒãã衚çŸã¯ãããŸããã
- prohibited_claims ã®ç¢ºèª: ç®èç§å°éå»ã®è¡šèšãªãïŒä»£è¡šé¢é·ïŒãå 端åçã®æå®äž»åŒµãªããSVF ã®å¹¹çްèæå®ãªããFDAæ¿èªã®æå®ãªãããæé«/1äœ/100%/宿²»/å¯äœçšãªãããªããå ·äœçãªäŸ¡æ Œãªããåªå£ã®æå®ãªã
å»åŠçå
責äºé
æ¬ã³ã³ãã³ãã¯äžè¬çãªå¥åº·æ
å ±ã®æäŸãç®çãšããŠãããå人å¥ã®èšºæã»æ²»çã¯å¿
ãå°éå»ã«ãçžè«ãã ããã
ã»ãªããã¯å»é¢(Cellinique) ã«ãŠã³ã»ãªã³ã°ã»ãäºçŽ
ãœãŠã«ç¹å¥åžæ±ååºããµã³ãã228 ãšã³ã¹ã³ãã« 2é, B1
é»è©± 02-6203-3434
蚺çæé æãé 10:00-19:00 / æ¯ææçµåææ¥ 10:00-16:30


